Thrombolytic therapy in patients with submassive pulmonary embolism [1] (multiple letters)

New England Journal of Medicine

Volumn 348, Issue 4, 2003, Pages 357-359

  Ashton, Rendell W ^a   Daniels, Craig E ^a   Ryu, Jay H ^a   Gunn, Nathaniel A ^b   Tierney Jr , Lawrence M ^b   Berlin, David A ^c   Dalen, James E ^d   Ajani, Andrew E ^e   Walksman, Ron ^f   Konstantinides, Stavros ^g   Kasper, Wolfgang ^h  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d Archives of Internal Medicine   (United States)

^e Royal Melbourne Hospital   (Austria)

^f WASHINGTON HOSPITAL CENTER   (United States)

^g UNIVERSITY OF GÖTTINGEN   (Germany)

^h ST JOSEFS HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN; PLACEBO; TISSUE PLASMINOGEN ACTIVATOR;

BLEEDING; BRAIN HEMORRHAGE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FIBRINOLYTIC THERAPY; HEMATOLOGICAL PARAMETERS; HUMAN; INCIDENCE; LETTER; LUNG ANGIOGRAPHY; LUNG EMBOLISM; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; THROMBOEMBOLISM; TREATMENT OUTCOME; BLOOD; NOTE; MORTALITY; UTILIZATION REVIEW; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; CLASSIFICATION; HEART RIGHT VENTRICLE FUNCTION; PULMONARY HYPERTENSION;

FIBRINOLYTIC AGENTS; HUMAN; PULMONARY EMBOLISM; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; HEPARIN; HUMANS; PARTIAL THROMBOPLASTIN TIME; DRUG THERAPY, COMBINATION; HEMORRHAGE; INTRACRANIAL HEMORRHAGES; HYPERTENSION, PULMONARY; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 0037461594     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200301233480416     Document Type: Letter

References (0)